Literature DB >> 31012394

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.

Amie C O'Donoghue1, Mihaela Johnson2, Helen W Sullivan1, Sarah Parvanta2, Sarah Ray2, Brian G Southwell2.   

Abstract

To determine how individual difference (age, cognition, and hearing) and risk presentation (audio frequency, speed, and organization) variables affect viewing of direct-to-consumer (DTC) prescription drug television ads, participants (N = 1,075) from four age groups across the adult lifespan took an in-person hearing examination, watched a DTC television ad, and responded to survey questions. Results showed that increased age was related to reduced cognition and hearing ability, as well as lower ad comprehension and risk recall. Greater speed and more complex organization of the ad's risk information lowered risk recall and claim recognition. Audio frequency had no effect. Cognitive abilities mediated the relationship between age and risk recall. Our findings suggest that older adults are likely to have more difficulty recalling and understanding the risks presented in DTC television ads. Risk information can be presented in ways that facilitate or inhibit recall and recognition among individuals across the lifespan.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31012394      PMCID: PMC7342495          DOI: 10.1080/10810730.2019.1606364

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  27 in total

1.  Television advertisement format and the provision of risk information about prescription drug products.

Authors:  Lewis H Glinert; Jon C Schommer
Journal:  Res Social Adm Pharm       Date:  2005-06

Review 2.  Use of supportive context by younger and older adult listeners: balancing bottom-up and top-down information processing.

Authors:  M Kathleen Pichora-Fuller
Journal:  Int J Audiol       Date:  2008-11       Impact factor: 2.117

Review 3.  Presbycusis.

Authors:  George A Gates; John H Mills
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

4.  Managing daily life with age-related sensory loss: cognitive resources gain in importance.

Authors:  Vera Heyl; Hans-Werner Wahl
Journal:  Psychol Aging       Date:  2011-11-07

5.  Effects of aging and task difficulty on divided attention performance.

Authors:  Joan M McDowd; Fergus I M Craik
Journal:  J Exp Psychol Hum Percept Perform       Date:  1988-05       Impact factor: 3.332

6.  Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004.

Authors:  Yuri Agrawal; Elizabeth A Platz; John K Niparko
Journal:  Arch Intern Med       Date:  2008-07-28

7.  Use of the open-ended questionnaire with patients and their significant others.

Authors:  K A Lormore; S D Stephens
Journal:  Br J Audiol       Date:  1994-04

8.  Sounds perceived as annoying by hearing-aid users in their daily soundscape.

Authors:  Åsa Skagerstrand; Stefan Stenfelt; Stig Arlinger; Joel Wikström
Journal:  Int J Audiol       Date:  2014-02-05       Impact factor: 2.117

9.  Hearing, Cognition, and Healthy Aging: Social and Public Health Implications of the Links between Age-Related Declines in Hearing and Cognition.

Authors:  M Kathleen Pichora-Fuller; Paul Mick; Marilyn Reed
Journal:  Semin Hear       Date:  2015-08

10.  Assessing hearing and cognition challenges in consumer processing of televised risk information: Validation of self-reported measures using performance indicators.

Authors:  Brian G Southwell; Sarah A Parvanta; Mihaela M Johnson; Amie C O'Donoghue; Helen W Sullivan; Sarah E Ray; Cynthia S Soloe; Christine N Davis; Nancy McKenna
Journal:  Prev Med Rep       Date:  2018-06-22
View more
  1 in total

1.  Utilization of adequate provision in prescription drug broadcast ads among low- and non-Internet users.

Authors:  Kevin R Betts; Kathryn J Aikin; Panne Burke; Stephanie Miles; Shane Mannis
Journal:  Health Mark Q       Date:  2021-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.